.svg)
The Department of Targeted Cancer Treatment at Mayom Hospital offers cutting-edge precision oncology using molecular profiling and biomarker-driven therapies. Our team of medical oncologists, molecular pathologists, and genetic counselors deliver highly personalized treatments that target specific cancer mutations — minimizing side effects and maximizing outcomes.
Why Choose Mayom Hospital for Targeted Cancer Treatment?
At Mayom Hospital, we go beyond one-size-fits-all chemotherapy. Using next-generation sequencing (NGS) and advanced diagnostics, we identify actionable mutations and match patients with FDA-approved targeted drugs and clinical trials for better survival and quality of life.
- Comprehensive Genomic Profiling: NGS panels for 500+ cancer genes
- Expert Molecular Tumor Board: Weekly review of complex cases
- Multidisciplinary Care: Collaboration with surgeons, radiologists, and pathologists
- Access to Latest Therapies: EGFR, ALK, BRAF, PARP, and TRK inhibitors
- Personalised Care: Treatment based on your tumor’s unique DNA profile
Symptoms That Need Genomic Evaluation
You should consider targeted therapy evaluation if you have:
- Advanced or metastatic cancer not responding to standard treatment
- Non-small cell lung cancer (NSCLC) or adenocarcinoma
- Breast, colorectal, or ovarian cancer with family history
- Rare or aggressive tumors with unknown primary
- Young-onset cancer (diagnosed under 50)
- Interest in clinical trials or off-label targeted drugs
Our Services
Molecular Diagnostics
- Next-Generation Sequencing (NGS) of tumor DNA
- Liquid biopsy for circulating tumor DNA (ctDNA)
Targeted Therapy Administration
- Oral tyrosine kinase inhibitors (TKIs)
- Monoclonal antibodies and PARP inhibitors
- Immunotherapy + targeted therapy combinations
Clinical Trials & Research
- Access to phase I-III targeted therapy trials
- Basket and umbrella trial enrollment
- Real-world evidence and outcomes research
Our Expert Team
Our precision oncology team includes board-certified medical oncologists, molecular pathologists, bioinformatics specialists, and genetic counselors. Backed by weekly tumor board reviews, they ensure every patient receives evidence-based, mutation-specific treatment.
Facilities & Infrastructure
To deliver world-class targeted therapy, our department is supported by:
- In-house NABL-accredited molecular diagnostics lab
- Dedicated infusion center for oral and IV targeted drugs
- Bioinformatics platform for genomic data analysis
- 24x7 oncology emergency and ICU backup
- On-site pharmacy with specialized cancer medications
Our Approach to Care
At Mayom Hospital, targeted therapy is about precision, hope, and progress. We analyze your cancer at the molecular level to deliver smarter, kinder, and more effective treatment — tailored to your tumor’s biology.
- Accurate Profiling: NGS and IHC biomarker testing
- Personalised Care: Mutation-matched drug selection
- Patient Education: Clear explanation of genomic results
- Safety First: Regular monitoring and resistance management
Testimonials
"After failing chemo, NGS revealed an EGFR mutation. Targeted therapy shrank my lung tumor in 6 weeks. I’m back to work!" - Sunita, Gurugram
"The team found a rare NTRK fusion in my sarcoma. A new drug not available elsewhere gave me 18 months of stability." - Vikram, Gurugram
Targeted therapy uses drugs that attack specific genetic mutations or proteins driving cancer growth, while sparing healthy cells — unlike traditional chemotherapy.
Patients with cancers harboring actionable mutations (e.g., EGFR, ALK, BRAF, HER2) identified through genomic testing are ideal candidates.
Next-generation sequencing (NGS) of tumor tissue or liquid biopsy to detect mutations, fusions, or amplifications that can be targeted.
Yes. We offer access to novel targeted agents, basket trials, and first-in-human studies for patients with rare or resistant mutations.
Book an Appointment
At Mayom Hospital, our Targeted Cancer Treatment program brings hope through science. Whether you need genomic testing, mutation-specific therapy, or access to clinical trials, our precision oncology team is here to guide you toward better outcomes.